D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IMGN holding history
ImmunoGen, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMGN overviewAll 13F holders of IMGNFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −4,522,797−100.0% | Sold out | Holders |
| Q4 2023 | 4,522,797 | $134.1M | 0.2% | −2,472,442−35.3% | Reduced | Holders |
| Q3 2023 | 6,995,239 | $111.0M | 0.2% | +714,723+11.4% | Added | Holders |
| Q2 2023 | 6,280,516 | $118.5M | 0.2% | +6,280,516 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −485,378−100.0% | Sold out | Holders |
| Q4 2022 | 485,378 | $2.41M | <0.1% | −193,754−28.5% | Reduced | Holders |
| Q3 2022 | 679,132 | $3.25M | <0.1% | −297,795−30.5% | Reduced | Holders |
| Q2 2022 | 976,927 | $4.40M | <0.1% | −274,750−22.0% | Reduced | Holders |
| Q1 2022 | 1,251,677 | $5.96M | <0.1% | −606,029−32.6% | Reduced | Holders |
| Q4 2021 | 1,857,706 | $13.8M | <0.1% | −228,529−11.0% | Reduced | Holders |
| Q3 2021 | 2,086,235 | $11.8M | <0.1% | −87,547−4.0% | Reduced | Holders |
| Q2 2021 | 2,173,782 | $14.3M | <0.1% | +342,538+18.7% | Added | Holders |
| Q1 2021 | 1,831,244 | $14.8M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.